In September, GE and leading healthcare and financial partners launched a new healthymagination initiative focused on accelerating cancer innovation and improving care for 10 million cancer patients around the world by 2020 . The plan was announced in New York by GE’s CEO and Chairman Jeff Immelt to an audience of prominent cancer scientists and researchers, doctors, financial partners and employees of GE Healthcare. The company’s comprehensive initiative combines the strength of GE’s portfolio of integrated cancer technologies with collaboration between GE and new partners and data sources to help clinicians provide better, more personalized care.
Since 1991, the National Breast Cancer Coalition — an influential disease lobbying organization — has promoted evidence-based medicine and focused its public policy advocacy on legislative priorities that encompass three primary goals: increased funding for breast cancer research, improved access to quality breast cancer care and clinical trials, and expanded influence of breast cancer advocates wherever and whenever breast cancer decisions are made.
Last month, the National Breast Cancer Coalition (NBCC) launched the Breast Cancer Deadline 2020 — a call to action for policymakers, researchers, breast cancer advocates and other stakeholders to end the disease by January 1st, 2020.
Recently, an undercover pharmacy investigation conducted by 20/20 and reported on by Chief Investigative Correspondent Brian Ross evaluated prescription dispensing at some of the best known U.S. chain drug stores.
The results are surprising and the suggestions at the end of this article really could save your life or that of someone you love.